Clinical trial
SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases
NCT05022420 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SAfety and TOlerance of the Biopsies in Auto-immune Rare dIseases
- Lead sponsor
- University Hospital, Brest
- Phase
- Observational
- Overall status
- Terminated
- Start date
- August 19, 2021
- Completion date
- March 16, 2025
- Enrollment
- 505 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
biopsy site itching, tolerance